FTR #23 Interview with Stephen Singular, Steven Worth and Donald Freed

Fur­ther dis­cus­sion with three authors whose books indi­cate that O.J. Simp­son is inno­cent of mur­der charges.

FTR #22 Interview with Stephen Singular, Steven Worth and Donald Freed

Three authors whose books indi­cate that O.J. Simp­son was framed.

FTR #638 Miscellaneous Articles and Updates

Bor­mann net­work con­trols major Ger­man cor­po­ra­tions; archive of Third Reich doc­u­ments; Rock­e­fellers push Exxon­Mo­bil to switch to renew­able ener­gy; Stan­dard Oil cor­po­rate com­plex; vio­lence in the Mus­lim world effects glob­al oil prices.

FTR #339: Walking the Snake, Part 4

‘Ser­pen­t’s Walk’ nov­el about Nazi takeover of the U.S. in the 21st cen­tu­ry, and recent events involv­ing racist and White Suprema­cist orga­ni­za­tions.

For The Record programs 1–99, Complete Audio

Down­load links to Dave Emory’s “For The Record” series, pro­grams 1 through 99.

FDA’s Unfortunate Ruling about Vaccine Monitoring

In the past, we not­ed numer­ous points of reser­va­tion we have about the Covid-19 vac­ci­na­tion pro­gram, includ­ing the mil­i­tary’s ground-lev­el involve­ment with the vac­ci­na­tion pro­gram. Now, we learn that Trump’s FDA grant­ed Big Phar­ma its wish, and elim­i­nat­ed the need for long-term test­ing for neg­a­tive side effects. We are not alone in our reser­va­tions: ” . . . . These aren’t cranks. Some are health care work­ers, includ­ing doc­tors and nurs­es, peo­ple you would think would be the first in line to get their shots giv­en their expo­sure to the virus. We’ve talked to sev­er­al peo­ple in health­care who have eschewed the vac­cine. Many of them have been around long enough that they’ve come to dis­trust Big Phar­ma and/or the FDA. . . .” We can but hope that we do not see a repeat of the tragedy fol­low­ing the con­t­a­m­i­na­tion of the polio vac­cine with a can­cer-caus­ing mon­key virus.

FTR #692 Women in the Klan (“Palin by Comparison,” Part 2)

Dis­cuss­es the role of women in the Ku Klux Klan. Women are a large, though unrec­og­nized part of the white suprema­cist move­ment today.

FTR #1166 Bio-Psy-Op Apocalypse Now, Part 22: A Pound of Cure, Part 1

Sup­ple­ment­ing FTR #1138, this pro­gram con­tin­ues dis­cus­sion about drug treat­ments for, and vac­cines to pre­vent, Covid-19.

In pre­vi­ous posts and pro­grams, we have not­ed that Mod­er­na’s vac­cine work has been financed by DARPA. We have also not­ed that the over­all head of Oper­a­tion Warp Speed is Mon­cef Slaoui, for­mer­ly in charge of prod­uct devel­op­ment for Mod­er­na!

Of great sig­nif­i­cance is the cen­tral role of the mil­i­tary in the devel­op­ment of treat­ment for Covid-19:

1.–The pro­gram notes that: ” . . . . Remde­sivir pre­dates this pan­dem­ic. It was first con­sid­ered as a poten­tial treat­ment for Ebo­la, and was devel­oped through a long­stand­ing part­ner­ship between the U.S. Army and the Cen­ters for Dis­ease Con­trol and Pre­ven­tion. . . .”
2.–Jonathan King has sound­ed the alarm about “vac­cine research” mask­ing offen­sive bio­log­i­cal war­fare research: “. . . . King, who has chaired the micro­bial phys­i­ol­o­gy study sec­tion for the NIH, believes that with­out inten­sive inde­pen­dent scruti­ny, the Pen­ta­gon is free to obscure its true goals. ‘The Defense Depart­ment appears to be pur­su­ing many nar­row, applied goals that are by nature offen­sive, such as the genet­ic ‘improve­ment’ of BW agents,’ King says. ‘But to achieve polit­i­cal accept­abil­i­ty, they mask these inten­tions under forms of research, such as vac­cine devel­op­ment, which sound defen­sive. . . .”
3.–Moderna’s vac­cine devel­op­ment was over­seen by an unnamed Pen­ta­gon offi­cial: ” . . . . Moderna’s team was head­ed by a Defense Depart­ment offi­cial whom com­pa­ny exec­u­tives described only as ‘the major,’ say­ing they don’t know if his name is sup­posed to be a secret. . . . .”
4.–The per­va­sive role of the mil­i­tary in Oper­a­tion Warp Speed (the Trump admin­is­tra­tion’s vac­cine devel­op­ment pro­gram) has gen­er­at­ed alarm in civil­ian par­tic­i­pants: “. . . . Scores of Defense Depart­ment employ­ees are laced through the gov­ern­ment offices involved in the effort, mak­ing up a large por­tion of the fed­er­al per­son­nel devot­ed to the effort.  Those num­bers have led some cur­rent and for­mer offi­cials at the Cen­ters for Dis­ease Con­trol and Pre­ven­tion to pri­vate­ly grum­ble that the military’s role in Oper­a­tion Warp Speed was too large for a task that is, at its core, a pub­lic health cam­paign. . . .”
5.–General Gus­tave Perna–one of the prin­ci­pals in Oper­a­tion Warp Speed–has cho­sen a retired Lieu­tenant Gen­er­al to over­see much of the pro­gram: ” . . . . ‘Frankly, it has been breath­tak­ing to watch,’ said Paul Ostrows­ki, the direc­tor of sup­ply, pro­duc­tion and dis­tri­b­u­tion for Oper­a­tion Warp Speed. He is a retired Army lieu­tenant gen­er­al who was select­ed to man­age logis­tics for the pro­gram by Gen. Gus­tave F. Per­na, the chief oper­at­ing offi­cer for Oper­a­tion Warp Speed. . . .”
6.–The mil­i­tary will be able to trace the des­ti­na­tion and admin­is­tra­tion of each dose: ” . . . . Mil­i­tary offi­cials also came up with the clever idea — if it works — to coor­di­nate the deliv­ery of vac­cines to drug­stores, med­ical cen­ters and oth­er immu­niza­tion sites by send­ing kits full of nee­dles, syringes and alco­hol wipes. Vac­cine mak­ers will be alert­ed when the kits arrive at an immu­niza­tion site so they know to ship dos­es. Once the first dose is giv­en, the man­u­fac­tur­er will be noti­fied so it can send the sec­ond dose with a patient’s name attached sev­er­al weeks lat­er. The mil­i­tary will also mon­i­tor vac­cine dis­tri­b­u­tion through an oper­a­tions cen­ter. ‘They will know where every vac­cine dose is,’ Mr. [Paul] Man­go said on a call with reporters. . . .”

This pro­gram begins with infor­ma­tion about the ongo­ing pro­fes­sion­al mas­sag­ing of Gilead Sci­ences’ anti-viral remde­sivir.

The most pos­i­tive stud­ies have proved remdesivir/Veklury only mod­est­ly suc­cess­ful against SARS Cov‑2 (the virus that caus­es Covid-19). Remde­sivir (now mar­ket­ed under the brand name Vek­lury) has been pro­pelled to the fore­front of treat­ment reg­i­mens for the pan­dem­ic, a devel­op­ment which appears to dimin­ish the chances for a com­pet­ing, more effec­tive drug to gain pro­fes­sion­al approval for treat­ing Covid-19.

” . . . . Oth­er stud­ies have shown no ben­e­fit, includ­ing the World Health Organization’s Sol­i­dar­i­ty tri­al, released as a preprint on Oct. 15. Based on these results, the Euro­pean Soci­ety of Inten­sive Care Med­i­cine is now rec­om­mend­ing that the drug not be rou­tine­ly used in hos­pi­tal­ized Covid-19 patients. Infec­tious dis­ease experts have stat­ed that after exam­in­ing all avail­able evi­dence, we can rea­son­ably con­clude only that remde­sivir may work. . . .”

Deeply dis­turb­ing, as well, is the news that the “pos­i­tive news” about vac­cine suc­cess and devel­op­ment has been gen­er­at­ed by press releas­es from the com­pa­nies that man­u­fac­ture them: ” . . . . But the com­pa­nies announced the find­ings in news releas­es, not in peer-reviewed sci­en­tif­ic jour­nals, and did not dis­close the detailed data that would allow out­side experts to eval­u­ate their claims. There­fore, the results can­not be con­sid­ered con­clu­sive. The fig­ures on effec­tive­ness may change as the stud­ies con­tin­ue. . . .”

Pro­gram High­lights Include: The rapid spread of the dis­ease is ben­e­fit­ting the speed-up of vac­cine research; review of the atten­u­at­ed, manip­u­lat­ed NIAID study on remde­sivir that gen­er­at­ed pos­i­tive news, a run-up in the stock price of Gilead Sci­ences and a boost for the mar­ket as a whole; review of the role of “Sci­en­tists to Stop Covid-19” in mas­sag­ing the vet­ting process for remde­sivir; review of the CDC’s clos­ing of the USAMRIID in August of 2019 and the test­ing of remdeisivir at that facil­i­ty in March of 2019; review of the insid­i­ous, inces­tu­ous rela­tion­ship between the author­i­ties “reg­u­lat­ing” treat­ment of Lyme Dis­ease and those who ben­e­fit from the admin­is­tra­tion of that treat­ment; review of Lyme Dis­ease as a bio­log­i­cal war­fare weapon.

Heads We Win, Tails You Lose: The Fascist Philosophy Behind Private Equity’s Leveraged Buyout of Everything

It’s been the same head­line for months now:
* April of 2020: Amer­i­can bil­lion­aires have got­ten $280 bil­lion rich­er since the start of the COVID-19 pan­dem­ic
* May of 2020: Amer­i­can bil­lion­aires got $434 rich­er dur­ing the pan­dem­ic
* August of 2020: Amer­i­can bil­lion­aires got $637 rich­er dur­ing the pan­dem­ic
* Sep­tem­ber of 2020: U.S. bil­lion­aires got $845 bil­lion rich­er since the start of the pan­dem­ic/Wealth of US bil­lion­aires ris­es by near­ly a third dur­ing pan­dem­ic
* Octo­ber of 2020: US bil­lion­aires saw their net worth rise by almost $1 tril­lion between March and Octo­ber — Jeff Bezos remains the rich­est, a study says.

From near­ly the start of the COVID-19 pan­dem­ic it’s been clear that the pub­lic health dis­as­ter was­n’t a dis­as­ter for every­one, with the wealth­i­est indi­vid­u­als being not only large­ly insu­lat­ed from the eco­nom­ic lock­down but in many cas­es well posi­tioned to prof­it from it. The pan­dem­ic was turn­ing into a giant upward trans­fer of wealth. And as we’re going to see, giant upward trans­fers of wealth are essen­tial­ly what the pri­vate equi­ty indus­try is all about. The rise of ‘sup­ply-side’ eco­nom­ics in the 1980s coin­cid­ed with the rise of pri­vate equi­ty and that’s no coin­ci­dence. The phi­los­o­phy behind the pri­vate equi­ty move­ment is the phi­los­o­phy of sup­ply-side eco­nom­ics. An anti-New Deal phi­los­o­phy, where ruth­less­ness is a virtue, that fueled a 40 year giant fas­cist lever­aged buy­out of soci­ety.

Does O.J. Simpson’s Life Matter?

The crim­i­nal and civ­il tri­als of O.J. Simp­son cap­ti­vat­ed the pub­lic aware­ness, yet the facts con­firm­ing, beyond doubt, O.J.‘s inno­cence were obscured by a blitzkrieg of media-assist­ed and gen­er­at­ed dis­in­for­ma­tion. Sup­ple­ment­ing the medi­a’s insti­tu­tion­al­ized lying was a grotesque dis­tor­tion of the record and out­right crim­i­nal behav­ior by ele­ments of the Los Ange­les legal estab­lish­ment. The very issues at the fore­front of the unrest over race and polic­ing were front and cen­ter in the case of Mark Fuhrman, yet the same pub­lic that is up in arms–literally–over George Floyd, Bre­an­na Tay­lor et al took no notice of the facts in the Simp­son case. Take a half hour to lis­ten to the linked autio of FTR #39, about Mark Fuhrman. Why was­n’t there more dis­cus­sion of this?